James B. Bucher
General Counsel bij HARPOON THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
James B.
Bucher currently works at Harpoon Therapeutics, Inc., as Chief Legal Officer from 2023.
Mr. Bucher also formerly worked at Exelixis, Inc., as Secretary & Vice President-Corporate Legal Affairs from 2013 to 2014, Shearman & Sterling LLP, as Partner from 2001 to 2007, Lundbeck Seattle BioPharmaceuticals, Inc., as Executive Vice President & General Counsel, and Eliem Therapeutics, Inc., as Executive Vice President & General Counsel.
Mr. Bucher received his undergraduate degree from Colgate University and graduate degree from Emory University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ELIEM THERAPEUTICS, INC.
-.--% | 31-10-2022 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van James B. Bucher
| Bedrijven | Functie | Begin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | General Counsel | 26-12-2023 |
Eerdere bekende functies van James B. Bucher
| Bedrijven | Functie | Einde |
|---|---|---|
| EXELIXIS, INC. | General Counsel | 01-01-2014 |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-2007 |
| ELIEM THERAPEUTICS, INC. | General Counsel | - |
| ALDER BIOPHARMACEUTICALS, INC. | General Counsel | - |
Opleiding van James B. Bucher
| Colgate University | Undergraduate Degree |
| Emory University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| HARPOON THERAPEUTICS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
